Ajanta Pharma (AJANTPHARM) Shareholding Pattern

NSE: AJANTPHARM • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 66.25%
FII Holding 7.98%
DII Holding 18.58%
Public Holding 6.44%
Total Shareholders 65,409
As of Dec 2025
View the latest shareholding pattern of Ajanta Pharma (AJANTPHARM) including promoter, FII, DII, and public holdings. Track AJANTPHARM ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See AJANTPHARM earnings valuation)

Ajanta Pharma (AJANTPHARM) Shareholding Summary

  • Promoter holding remains unchanged at 66.25% in Dec 2025
  • FII/FPI have decreased holdings from 8.53% to 7.98% in Dec 2025
  • DIIs have increased holdings from 17.90% to 18.58% in Dec 2025
  • Institutional investors have increased holdings from 26.43% to 26.56% in Dec 2025
  • Number of shareholders decreased from 67,785 to 65,409 in Dec 2025

AJANTPHARM Quarterly Ownership Changes

Quarter-over-quarter changes for Ajanta Pharma from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
-0.55%
DII Holding Change
Sept 2025 to Dec 2025
+0.68%
Public Holding Change
Sept 2025 to Dec 2025
-0.09%

Ajanta Pharma (AJANTPHARM) Quarterly Shareholding Trends

Visual breakdown of AJANTPHARM ownership distribution over time. Learn more about Ajanta Pharma yearly highs lows.

Promoter
FII
DII
Public
Government

Rising institutional holdings in AJANTPHARM often correlate with improved fundamentals. Check out AJANTPHARM share price history.

Ajanta Pharma (AJANTPHARM) Shareholding Data

Download complete AJANTPHARM ownership data for offline analysis. Discover Ajanta Pharma market cap.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 66.25% 7.98% 18.58% 0.01% 6.44% 0.76% 100.02% 65,409
Sept 2025 66.25% 8.53% 17.90% 0.01% 6.53% 0.79% 100.01% 67,785
Jun 2025 66.26% 8.86% 17.50% 0.01% 6.59% 0.79% 100.01% 68,882
Mar 2025 66.26% 8.86% 17.48% 0.01% 6.63% 0.76% 100.00% 70,827
Dec 2024 66.26% 9.26% 17.02% 0.01% 6.67% 0.79% 100.01% 66,896
Sept 2024 66.26% 9.11% 17.10% 0.01% 6.71% 0.80% 99.99% 64,315
Jun 2024 66.27% 8.36% 17.41% 0.01% 7.08% 0.86% 99.99% 70,316
Mar 2024 66.21% 8.54% 17.49% 0.00% 6.91% 0.84% 99.99% 55,488
Dec 2023 66.21% 0.00% 16.01% 0.00% 7.07% 10.70% 99.99% 54,351
Sept 2023 66.21% 0.00% 14.91% 0.00% 7.21% 11.67% 100.00% 56,277
Jun 2023 66.21% 0.00% 14.70% 0.00% 6.92% 12.16% 99.99% 54,874
Apr 2023 66.21% 0.00% 16.02% 0.00% 6.94% 10.82% 99.99% 56,939
Mar 2023 66.11% 0.00% 15.98% 0.00% 7.10% 10.82% 100.01% 83,549
Dec 2022 66.11% 0.00% 15.82% 0.00% 7.17% 10.90% 100.00% 59,798
Sept 2022 70.48% 0.00% 12.15% 0.00% 7.31% 10.06% 100.00% 62,048
Jun 2022 70.48% 0.00% 11.92% 0.45% 7.45% 9.70% 100.00% 64,445
Mar 2022 70.48% 0.00% 11.61% 0.45% 7.33% 10.13% 100.00% 60,759
Dec 2021 70.34% 0.00% 11.55% 0.45% 7.29% 10.37% 100.00% 57,897
Sept 2021 70.34% 0.00% 11.51% 0.43% 7.45% 10.26% 99.99% 52,263
Jun 2021 70.34% 0.00% 11.04% 0.43% 7.42% 10.76% 99.99% 45,664
Mar 2021 70.34% 0.00% 10.88% 0.76% 7.64% 10.37% 99.99% 44,881

AJANTPHARM promoter holding above 50% indicates strong insider confidence. Explore the Ajanta Pharma dividend policy for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 66.25% 7.98% 18.58% 0.01% 6.44% 0.76% 100.02% 65,409
Sept 2025 66.25% 8.53% 17.90% 0.01% 6.53% 0.79% 100.01% 67,785
Jun 2025 66.26% 8.86% 17.50% 0.01% 6.59% 0.79% 100.01% 68,882
Mar 2025 66.26% 8.86% 17.48% 0.01% 6.63% 0.76% 100.00% 70,827
Dec 2024 66.26% 9.26% 17.02% 0.01% 6.67% 0.79% 100.01% 66,896
Sept 2024 66.26% 9.11% 17.10% 0.01% 6.71% 0.80% 99.99% 64,315
Jun 2024 66.27% 8.36% 17.41% 0.01% 7.08% 0.86% 99.99% 70,316
Mar 2024 66.21% 8.54% 17.49% 0.00% 6.91% 0.84% 99.99% 55,488
Dec 2023 66.21% 0.00% 16.01% 0.00% 7.07% 10.70% 99.99% 54,351
Sept 2023 66.21% 0.00% 14.91% 0.00% 7.21% 11.67% 100.00% 56,277
Jun 2023 66.21% 0.00% 14.70% 0.00% 6.92% 12.16% 99.99% 54,874
Apr 2023 66.21% 0.00% 16.02% 0.00% 6.94% 10.82% 99.99% 56,939

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 66.25% 7.98% 18.58% 0.01% 6.44% 0.76% 100.02% 65,409
Dec 2024 66.26% 9.26% 17.02% 0.01% 6.67% 0.79% 100.01% 66,896
Dec 2023 66.21% 0.00% 16.01% 0.00% 7.07% 10.70% 99.99% 54,351
Dec 2022 66.11% 0.00% 15.82% 0.00% 7.17% 10.90% 100.00% 59,798
Dec 2021 70.34% 0.00% 11.55% 0.45% 7.29% 10.37% 100.00% 57,897

Year-over-year trends reveal long-term ownership shifts.

Understanding Ajanta Pharma (AJANTPHARM) Shareholding Pattern

Ajanta Pharma shareholding pattern reveals who owns AJANTPHARM stock and how ownership changes over time. High promoter stakes in AJANTPHARM often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your AJANTPHARM trades. AJANTPHARM Q4 results

Combine AJANTPHARM ownership analysis with price movements and financial performance for a complete investment picture. (See AJANTPHARM fair price)